Can Past Psychedelic Use Mitigate the Severity of Opioid Use Disorder?: Case Report of a Musician.
Asim Trimzi, Morgan Campbell
Delaware journal of public health June 1, 2024 DOI: 10.32481/djph.2024.06.08 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | An award-winning musician with extensive history of hallucinogen use |
| Topics | Addiction |
| Key findings | The case illustrates how early hallucinogen use may have impacted the musician's wellbeing and opioid experience. |
Abstract
Little is known about the association between psychedelic use and substance abuse in the general population. We present a case of an award winning musician with an extensive history of hallucinogen use during his early life and how this impacted his overall wellbeing and opioid experience.
Comparable studies
Other case reports and case series on addiction, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Ecstasy (MDMA) dependence Individuals meeting criteria for MDMA dependence | 1999 | Case series | n = 3 |
| Potential Human Neurotoxicity of MDMA (‘Ecstasy’): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies Polydrug consumers attending a Public Health Addiction Treatment Unit in Italy | 2000 | Review and clinical case series | |
| A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder. 31-year-old male military veteran with moderate alcohol use disorder | 2018 | Case study | n = 1 |
| LSD Overdoses: Three Case Reports Three individuals who experienced accidental LSD overdose | 2020 | Case series | n = 3 |
| Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report. 37-year-old female with severe opioid use disorder | 2016 | Case study | n = 1 |
Citations in the library
Cites 4
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine Journal of Neuroscience November 30, 2020
- Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. The American Journal of Drug and Alcohol Abuse 2018
- Psychedelics in Psychiatry-Keeping the Renaissance From Going Off the Rails. JAMA Psychiatry May 1, 2021